Cargando…
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
INTRODUCTION: Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and th...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995918/ https://www.ncbi.nlm.nih.gov/pubmed/35404010 http://dx.doi.org/10.1007/s40121-022-00625-9 |
_version_ | 1784684387812507648 |
---|---|
author | Briano, Federica Magnasco, Laura Sepulcri, Chiara Dettori, Silvia Dentone, Chiara Mikulska, Malgorzata Ball, Lorenzo Vena, Antonio Robba, Chiara Patroniti, Nicolò Brunetti, Iole Gratarola, Angelo D’Angelo, Raffaele Di Pilato, Vincenzo Coppo, Erika Marchese, Anna Pelosi, Paolo Giacobbe, Daniele Roberto Bassetti, Matteo |
author_facet | Briano, Federica Magnasco, Laura Sepulcri, Chiara Dettori, Silvia Dentone, Chiara Mikulska, Malgorzata Ball, Lorenzo Vena, Antonio Robba, Chiara Patroniti, Nicolò Brunetti, Iole Gratarola, Angelo D’Angelo, Raffaele Di Pilato, Vincenzo Coppo, Erika Marchese, Anna Pelosi, Paolo Giacobbe, Daniele Roberto Bassetti, Matteo |
author_sort | Briano, Federica |
collection | PubMed |
description | INTRODUCTION: Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and the potential high mortality of C. auris infections represent an important challenge for physicians. METHODS: We conducted a single-center retrospective study including all patients admitted to ICUs with isolation of C. auris in any non-sterile body site between February 20, 2020, and May 31, 2021. The primary aim of the study was to assess the cumulative incidence of C. auris candidemia in colonized patients. The secondary aim was to identify predictors of C. auris candidemia in the study population. RESULTS: During the study period, 157 patients admitted to ICUs in our hospital became colonized with C. auris; 59% of them were affected by COVID-19. Overall, 27 patients (17%) developed C. auris candidemia. The cumulative risk of developing C. auris candidemia was > 25% at 60 days after first detection of C. auris colonization. Seven patients with C. auris candidemia (26%) also developed a late recurrent episode. All C. auris blood isolates during the first occurring episode were resistant to fluconazole and susceptible to echinocandins, while 15 (56%) were resistant to amphotericin B. During late recurrent episodes, emergent resistance to caspofungin and amphotericin B occurred in one case each. In the final multivariable model, only multisite colonization retained an independent association with the development of C. auris candidemia. CONCLUSION: Candida auris candidemia may occur in up to one fourth of colonized critically ill patients, and multisite colonization is an independent risk factor for the development of candidemia. Implementing adequate infection control measures remains crucial to prevent colonization with C. auris and indirectly the subsequent development of infection. |
format | Online Article Text |
id | pubmed-8995918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-89959182022-04-11 Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors Briano, Federica Magnasco, Laura Sepulcri, Chiara Dettori, Silvia Dentone, Chiara Mikulska, Malgorzata Ball, Lorenzo Vena, Antonio Robba, Chiara Patroniti, Nicolò Brunetti, Iole Gratarola, Angelo D’Angelo, Raffaele Di Pilato, Vincenzo Coppo, Erika Marchese, Anna Pelosi, Paolo Giacobbe, Daniele Roberto Bassetti, Matteo Infect Dis Ther Original Research INTRODUCTION: Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and the potential high mortality of C. auris infections represent an important challenge for physicians. METHODS: We conducted a single-center retrospective study including all patients admitted to ICUs with isolation of C. auris in any non-sterile body site between February 20, 2020, and May 31, 2021. The primary aim of the study was to assess the cumulative incidence of C. auris candidemia in colonized patients. The secondary aim was to identify predictors of C. auris candidemia in the study population. RESULTS: During the study period, 157 patients admitted to ICUs in our hospital became colonized with C. auris; 59% of them were affected by COVID-19. Overall, 27 patients (17%) developed C. auris candidemia. The cumulative risk of developing C. auris candidemia was > 25% at 60 days after first detection of C. auris colonization. Seven patients with C. auris candidemia (26%) also developed a late recurrent episode. All C. auris blood isolates during the first occurring episode were resistant to fluconazole and susceptible to echinocandins, while 15 (56%) were resistant to amphotericin B. During late recurrent episodes, emergent resistance to caspofungin and amphotericin B occurred in one case each. In the final multivariable model, only multisite colonization retained an independent association with the development of C. auris candidemia. CONCLUSION: Candida auris candidemia may occur in up to one fourth of colonized critically ill patients, and multisite colonization is an independent risk factor for the development of candidemia. Implementing adequate infection control measures remains crucial to prevent colonization with C. auris and indirectly the subsequent development of infection. Springer Healthcare 2022-04-11 2022-06 /pmc/articles/PMC8995918/ /pubmed/35404010 http://dx.doi.org/10.1007/s40121-022-00625-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Briano, Federica Magnasco, Laura Sepulcri, Chiara Dettori, Silvia Dentone, Chiara Mikulska, Malgorzata Ball, Lorenzo Vena, Antonio Robba, Chiara Patroniti, Nicolò Brunetti, Iole Gratarola, Angelo D’Angelo, Raffaele Di Pilato, Vincenzo Coppo, Erika Marchese, Anna Pelosi, Paolo Giacobbe, Daniele Roberto Bassetti, Matteo Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors |
title | Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors |
title_full | Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors |
title_fullStr | Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors |
title_full_unstemmed | Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors |
title_short | Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors |
title_sort | candida auris candidemia in critically ill, colonized patients: cumulative incidence and risk factors |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995918/ https://www.ncbi.nlm.nih.gov/pubmed/35404010 http://dx.doi.org/10.1007/s40121-022-00625-9 |
work_keys_str_mv | AT brianofederica candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT magnascolaura candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT sepulcrichiara candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT dettorisilvia candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT dentonechiara candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT mikulskamalgorzata candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT balllorenzo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT venaantonio candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT robbachiara candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT patronitinicolo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT brunettiiole candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT gratarolaangelo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT dangeloraffaele candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT dipilatovincenzo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT coppoerika candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT marcheseanna candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT pelosipaolo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT giacobbedanieleroberto candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors AT bassettimatteo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors |